期刊文献+

如何看待关于决奈达隆的不同信息 被引量:1

原文传递
导出
摘要 近来,有关新的抗心律失常药决奈达隆(dronedarone)信息引起了许多关注,其临床疗效与安全性、适应证与禁忌证已经陆续有报道,但也有上市后发现副作用和有关其临床试验(PALLAS研究)被提前终止的消息。该药品尚未在我国上市,如何看待这一新药却已经成为一个较为热门的话题。
作者 朱俊
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第12期1151-1152,共2页 Chinese Journal of Cardiology
  • 相关文献

参考文献6

  • 1Touboul P,Brugada J,Cappuci A,et al.Donedarone for prevention of atrial fibrillation:a dose ranging study.Eur Heart J,2003,24:1481-1487.
  • 2Singh BN,Connolly SJ,Crijns HJGM,et al.Rronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.N Engl J Med,2007,357:987-999.
  • 3Davy JM,Herold M,Hoglund C,et al.Dronedarone for the control of ventricular rate in permanent atrial fibrillation:the efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study.Am Heart J,2008,156:527-529.
  • 4Connolly SJ,Crijns HJGM,Christian TP,et al.Analysis of stroke in ATHENA:a placebo-controlled,double-blind,parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.Circulation,2009,120:1174-1180.
  • 5Heuzey JY,Ferrari G,Radzik D,et al.A short-term,randomized,double-blind,parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation:the DIONYSOS study.J Cardiovasc Electrophysio1,2010,21:597-605.
  • 6K(φ)ber L,Torp-Pedersen C,McMurray JJ,et al.Increased mortality after dronedarone therapy for severe heart failure.N Engl J Med,2008,358:2678-2687.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部